Your browser doesn't support javascript.
loading
A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.
Chughtai, Bilal; Rojanasarot, Sirikan; Neeser, Kurt; Gultyaev, Dmitry; Fu, Shuai; Bhattacharyya, Samir K; El-Arabi, Ahmad M; Cutone, Ben J; McVary, Kevin T.
Afiliação
  • Chughtai B; Department of Urology, Weill Cornell Medicine, New York, New York, United States of America.
  • Rojanasarot S; Boston Scientific, Marlborough, MA, United States of America.
  • Neeser K; Certara Evidence & Access, Lörrach, BW, Germany.
  • Gultyaev D; Certara Evidence & Access, Lörrach, BW, Germany.
  • Fu S; Certara Evidence & Access, Lörrach, BW, Germany.
  • Bhattacharyya SK; Boston Scientific, Marlborough, MA, United States of America.
  • El-Arabi AM; Center for Male Health, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, United States of America.
  • Cutone BJ; Boston Scientific, Marlborough, MA, United States of America.
  • McVary KT; Center for Male Health, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, United States of America.
PLoS One ; 17(4): e0266824, 2022.
Article em En | MEDLINE | ID: mdl-35427376
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Ressecção Transuretral da Próstata Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Ressecção Transuretral da Próstata Idioma: En Ano de publicação: 2022 Tipo de documento: Article